Claudin-7 Levels Decrease Early in Colorectal Cancer Development
Author Information
Author(s): Bornholdt Jette, Friis Stine, Godiksen Sine, Poulsen Steen S, Santoni-Rugiu Eric, Bisgaard Hanne C, Lothe Inger MB, Ikdahl Tone, Tveit Kjell M, Johnson Egil, Kure Elin H, Vogel Lotte K
Primary Institution: Department of Cellular and Molecular Medicine, Faculty of Health Science, University of Copenhagen, Denmark
Hypothesis
Is claudin-7 expression decreased during colorectal carcinogenesis?
Conclusion
Claudin-7 mRNA levels are significantly reduced early in colorectal carcinogenesis, likely contributing to compromised epithelial barriers.
Supporting Evidence
- A 2.7-fold reduction in claudin-7 mRNA was found in carcinomas compared to healthy individuals.
- Reductions in claudin-7 levels were also observed in mild/moderate and severe dysplasia.
- The decrease in claudin-7 was confirmed at the protein level through immunohistochemistry.
Takeaway
This study found that claudin-7, a protein that helps keep cells together, is lower in people with early signs of colon cancer, which might make it easier for harmful substances to enter the body.
Methodology
The study measured claudin-7 mRNA levels in tissue samples from healthy individuals, dysplastic individuals, and colorectal cancer patients using quantitative real-time RT-PCR and confirmed findings with immunohistochemistry.
Limitations
The study did not adjust for gender differences in colorectal cancer incidence.
Participant Demographics
The study included 18 healthy individuals, 100 with mild/moderate dysplasia, 13 with severe dysplasia, and 121 colorectal cancer patients.
Statistical Information
P-Value
p<0.001 for carcinoma comparison
Confidence Interval
95% CI: 1.4-2.9 for normal adjacent samples
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website